Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × enzalutamide × Clear all

NCT02489123 2021-08-10

Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Phase 2 Terminated

8 enrolled 13 charts

Lymphoma, Mantle-Cell